Laboratory Manager, NGS Diagnostics, T-BAG Molecular Pathology Baden-Württemberg, Stuttgart, Germany
BIOGRAPHY
March 21, 2024 4:05 PM CET
Experience using the ODxET-Assay with focus on lung cancer samples - FFPE and liquid biopsy
Presented at:
OncomineWorld 2024: A Virtual NGS Education Meeting
Speaker
Abstract
Dr Sander will discuss his laboratory's pathology service and the types of samples that they receive. He will discuss the rationale behind introducing a CE-IVD testing and discuss the impact this has had on their patients. Dr Sander will also discuss how they have been transitioning to complementary liquid biopsy testing when FFPE samples are insufficient.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...